Interview with CombiGene’s new CMC expert

The Swedish Gene Therapy Company CombiGene aims to complete its preclinical program for the epilepsy project CG01 this year, in order to begin studies...

Carbiotix – improving gut health

Scientist have been able to link the insufficient production of metabolites in the gut to a number of  common diseases such as inflammatory bowel...

Company update Cereno Scientific – a rare opportunity in cardiovascular diseases

Cardiovascular diseases (CVD) are the most common cause of death in the world. An estimated 17,9 million people are expected to die every year,...

Status report Xintela – Integrins marking the future

Xintela was founded in 2009 by Evy Lundgren-Åkerlund based on her research and discoveries on the properties of the marker protein integrin α10β1. Since...

Status report CombiGene – In the front line of gene therapy

In recent years, gene therapies have emerged as one of the hottest areas within life science and the temperature is rising as the first...

Gabather – focus on CNS diseases

Diseases of the central nervous system (CNS) and mental health issues represent a major burden on society, and there is considerable room for improvements...

Coegin Pharma brings new vision for cancer treatment

The Nordic biotech Coegin Pharma is responding to calls for new cancer therapeutics by offering a novel approach to cancer treatment through the inhibition...

Abliva’s Chairman of the Board speaks to CEO change

Biopharma company Abliva started this year’s news cycle with big news when it announced a change of CEO on Wednesday evening. The Board has,...

Invent Medic wants to improve life for women with stress urinary...

Lund-based Invent Medic develops and markets products to improve quality of life and health for women. The first product marketed under the Efemia brand...

Fluicell harnessing microfluidics to spearhead the Biomedical field

Despite being a small company, Fluicell has already positioned itself as a pioneer in the field of single-cell investigations by developing innovative technologies. To...